AKTS
Aktis Oncology, Inc.
22.90$
+0.7%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | |
| – | 11.3% | 648.9% | 84.4% | 70.2% | 134.9% | 127.0% | – | 111.5% | 1,887.9% | – | |
| – | 88.7% | -548.9% | 15.6% | 29.8% | -34.9% | -27.0% | – | -11.5% | 100.0% | 100.0% | |
| – | 690.1% | 26,089.2% | 1,098.4% | 1,333.7% | 1,146.5% | 232.6% | – | 95.6% | 2,754.1% | 1,038.2% | |
| – | 1,151.8% | 35,482.7% | 728.9% | 603.0% | 608.4% | 134.9% | – | 28.3% | 760.4% | 193.9% | |
| – | 1,742.0% | 58,804.1% | 1,827.3% | 1,936.7% | 1,755.0% | 367.5% | – | 128.3% | 3,600.3% | 1,249.5% | |
| – | -1,842.0% | -58,704.1% | -1,844.4% | -1,906.9% | -1,789.8% | -394.5% | – | -128.3% | -3,500.3% | -1,149.5% | |
| – | – | – | 27.3% | 200.0% | 255.5% | 0.5% | – | 8.6% | 178.7% | – | |
| – | -2,121.4% | -53,691.6% | -1,799.8% | -2,026.9% | -2,019.0% | -397.6% | – | -105.6% | -2,957.6% | -980.9% | |
| – | 759.6% | -10,013.7% | 16.3% | 113.0% | – | -11.9% | – | -9.0% | 0.4% | – | |
| – | -2,121.4% | -53,691.6% | -1,799.8% | -2,139.9% | -2,283.1% | -385.6% | – | -105.6% | -2,957.6% | -980.9% | |
| – | -1,518.6% | -62,329.0% | -1,707.1% | -1,737.4% | -1,617.8% | -344.1% | – | -101.2% | -2,851.7% | -945.1% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.